HNSCC
Clinical trials for HNSCC explained in plain language.
Never miss a new study
Get alerted when new HNSCC trials appear
Sign up with your email to follow new studies for HNSCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a guided missile for chemo hit tumors harder and spare healthy tissue?
Disease control Not yet recruitingResearchers are testing a new drug called TS-104 in adults with advanced solid tumors, including lung, head and neck, ovarian, endometrial, esophageal, and gastric cancers. TS-104 is a peptide drug conjugate: it uses a targeting peptide to carry the chemotherapy drug MMAE directl…
Matched conditions: HNSCC
Phase 1 • Sponsor: TwoStep Therapeutics, Inc. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can a Three-Drug combo wipe out head and neck tumors before surgery?
Disease control Not yet recruitingThis trial is testing whether giving a combination of two newer drugs—an immunotherapy called adebrelimab and a targeted therapy called dalpiciclib—along with standard chemotherapy (cisplatin) before surgery can improve outcomes for people with locally advanced head and neck canc…
Matched conditions: HNSCC
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Iron nanoparticles could supercharge radiation against cancer
Disease control Not yet recruitingThis Phase 2 trial tests an experimental iron nanoparticle injection (CNSI-Fe) given directly into tumors along with standard radiotherapy. The goal is to see if the combination shrinks tumors better than radiation alone. The study will enroll 52 adults with head and neck cancer …
Matched conditions: HNSCC
Phase 2 • Sponsor: Sichuan Enray Pharmaceutical Sciences Company • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New blood test aims to predict which cancer patients will benefit from immunotherapy
Diagnosis Not yet recruitingThis study is developing a blood test called NeutroFlow that measures specific immune cells (neutrophils) to predict whether cancer patients will benefit from immunotherapy. Researchers will collect blood samples from 600 patients with several types of cancer before they start tr…
Matched conditions: HNSCC
Sponsor: OncoHost Ltd. • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
Can a glowing drug light up head and neck tumors?
Knowledge-focused Not yet recruitingThis early-phase trial is testing whether injecting a fluorescently labeled version of the immunotherapy drug nivolumab directly into head and neck tumors is safe and helps visualize the tumor and nearby lymph nodes during surgery. Adults with head and neck squamous cell carcinom…
Matched conditions: HNSCC
Early phase 1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC